论文部分内容阅读
为探讨血吸虫病大肠癌肝转移病人的生存与其相关因素之间的关系，我们对５０例血吸虫病大肠癌肝转移病人的临床因素、生活质量、肿瘤大小、血清碱性磷酸酶、百分肝取代和体重进行评估。生存期与血清碱性磷酸酶水平之间存在负相关（Ｐ＜０．００５），百分肝取代＞１３％者与≤１３％者之间，生存期无差异。生存期与体质、焦虑症、抑郁症、疾病影响侧面和Ｋａｒｎｏｆｓｋｙ评分之间亦存在负相关（Ｐ＜０．０５）。体质评分是关于生存者依赖的唯一生存质量变量（调整Ｒ２＝０．３５）。在转移早期，肿瘤增长，百分肝取代和体重碱轻不会使癌症患者进行性恶化。血吸虫病大肠癌肝转移病人的生存与临床因素、生活质量、血清碱性磷酸酶水平有关，在肝转移早期与肿瘤大小，体重碱轻无关
To investigate the relationship between survival and related factors in schistosomiasis patients with liver metastases of colorectal cancer, we compared the clinical factors, quality of life, tumor size, serum alkaline phosphatase, and percent liver replacement in 50 patients with schistosomiasis and colorectal liver metastases. And weight assessment. There was a negative correlation between serum alkaline phosphatase levels and survival time (P<0.005). There was no difference in survival time between percent liver replacements>13% and ≤13%. There was also a negative correlation between survival time and physical fitness, anxiety, depression, side effects of disease and Karnofsky score (P<0.05). Physical fitness score is the only quality of life variable for survivor dependence (adjustment R2=0.35). In the early stages of metastasis, tumor growth, percent liver replacement, and weight-alkaline weight do not worsen cancer patients. Survival of schistosomiasis patients with liver metastases from colorectal cancer is related to clinical factors, quality of life, and serum alkaline phosphatase levels. It has nothing to do with the size of the tumor and weight of alkali in the early stage of liver metastasis.